Abstract | INTRODUCTION: The pituitary adenomas secreting thyrotropin (TSH) are considered the rarest type of hormonally active pituitary tumour. In spite of that, many cases are described in the literature. On the other hand, the observations of the co-expression of TSH with other pituitary hormones (mostly with growth hormone [GH]) and "silent" expression of TSH in clinically non-functioning pituitary adenomas (CNFPA) are rather scarce. MATERIAL AND METHODS: RESULTS: TSH immunopositivity was found in 4.2% of CNFPA (3/71 tumours) and in 13.6% (3/22) cases of somatotropinomas manifesting as active acromegaly. All of the examined TSH-immunopositive adenomas expressed SSTR subtypes except SSTR4. The symptoms of hyperthyroidism were not observed in any of the acromegalic patients co-expressing TSH with GH. CONCLUSIONS: Our data confirm the relative rarity of TSH expression or co-expression of TSH in pituitary tumours. In most cases TSH is co-expressed with GH in patients with acromegaly and is not accompanied by hyperthyroidism. The "silent" expression of TSH may occur also, although rarely in CNFPA. The strong expression of SSTR in TSH-immunopositive CNFPA ("silent thyrotropinoma") indicates the possibility of the treatment of these tumours with somatostatin analogues. (Endokrynol Pol 2016; 67 (5): 515-518).
|
Authors | Marek Pawlikowski, Hanna Pisarek, Maria Jaranowska, Maciej Radek, Katarzyna Winczyk, Jolanta Kunert-Radek |
Journal | Endokrynologia Polska
(Endokrynol Pol)
Vol. 67
Issue 5
Pg. 515-518
( 2016)
ISSN: 2299-8306 [Electronic] Poland |
PMID | 27403655
(Publication Type: Journal Article)
|
Chemical References |
- Receptors, Somatostatin
- Human Growth Hormone
- Thyrotropin
|
Topics |
- Acromegaly
(etiology, metabolism)
- Adenoma
(complications, metabolism)
- Adult
- Female
- Human Growth Hormone
(metabolism)
- Humans
- Male
- Middle Aged
- Pituitary Neoplasms
(complications, metabolism)
- Receptors, Somatostatin
(metabolism)
- Thyrotropin
(metabolism)
- Young Adult
|